IPC Welcomes Oruka Therapeutics as a 2025 Bronze Level Corporate Member

We’re excited to announce that Oruka Therapeutics has joined the International Psoriasis Council as a 2025 Bronze Level Corporate Member. Oruka is a pioneering biopharmaceutical company advancing potentially best-in-class monoclonal antibody therapies for plaque psoriasis, psoriatic arthritis, and related inflammatory skin conditions. Their seasoned team of biopharma professionals is dedicated to improving patient experiences through innovative biologic treatments.

“We’re delighted to welcome Oruka into the IPC community,” said IPC CEO Christy Langan. “Their focus on developing targeted antibody therapies will deepen our collective understanding of psoriasis biology and support our goal of improving care for people living with this disease.”

Please join us in extending a warm welcome to Oruka.

Learn more about Oruka Therapeutics.

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

Approaching Challenging Patient Interactions with Empathy

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

Also Read

Six people stand side by side in business attire, smiling at the camera. Behind them, a banner reads IPC International Council 2025 Think Tank Puerto Rico, focused on Psoriasis in Latin America, with colorful designs and sunlight filtering through curtains.

International Psoriasis Council

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.

Wednesday, April 29, 2026

Map of South America with logos of IFPA, IPC, GRAPPA, PANLAR, SOLAPSO, and COLAPPIEL—organizations related to psoriasis and rheumatology—displayed around the continent.

multidisciplinary care psoriasis

International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America

A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.

Monday, April 27, 2026

Banner for the International Psoriasis Council featuring the text Councilor Spotlight, with headshots of IPC Councilors—a woman and a man—in separate frames below. The background showcases colorful geometric patterns in the corners.

education

IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder

The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.

Tuesday, April 21, 2026

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

Approaching Challenging Patient Interactions with Empathy

How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.

Thursday, May 21, 2026

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering disease modification, immune pathways, therapeutic escape, and psoriasis treatment response.

Friday, May 29, 2026

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Advancing Knowledge. Improving Care.

IPC Welcomes Oruka Therapeutics as a 2025 Bronze Level Corporate Member

Categories

Recent Posts

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

Approaching Challenging Patient Interactions with Empathy

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

Also Read

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America

IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder

Subscribe to the IPC Newsletter

Quick Links

Follow us

Approaching Challenging Patient Interactions with Empathy

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

Use and Misuse of Systemic Corticosteroids in Psoriasis

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Wednesday, May 27, 2026